Birth defect classification by organ system: A novel approach to heighten teratogenic signalling in a pregnancy registry

Pharmacoepidemiology and Drug Safety

Volumn 11, Issue 6, 2002, Pages 465-475

  Scheuerle, Angela ^a,c   Tilson, Hugh ^b  

^a Genetics Teratology and Ethics Consulting   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c NONE   (United States)

Author keywords

Antiretroviral; Birth defect; Epidemiology; Pregnancy; Registry; Teratogen

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; BIRTH DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EXPOSURE; EMBRYOLOGY; HUMAN; NOMENCLATURE; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; REGISTER; SIGNAL TRANSDUCTION; STANDARD; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANTI-HIV AGENTS; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PREGNANCY; REGISTRIES;

EID: 0036750747     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.726     Document Type: Article

References (6)

1. Kohn LT, Corrigan JM, Donaldson MS (eds). To Err Is Human: Building a Safer Health System. Committee on Quality of Health Care in America, Institute of Medicine. National Academy Press: Washington DC, 1999. Executive summary available at: http://www.iom.edu/iom/iomhome.nsf/WFiles/ ToErr-8pager/$file/ToErr-8pager.pdf [Last accessed on 4 March 2002].
2. Edmonds LD. Birth defect surveillane a the state and local level. Teratology 1997; 56: 5-7.
3. Honein MA, Paulozzi LJ, Cragan JD, Correa A. Evaluation of selected characteristics of pregnancy drug registries. Teratology 1999; 60: 356-364.
4. Six-digit codes for reportable birth defects based on the British Pediatric Association (BPA) Classification of Diseases (1979) and the World Health Organization's International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) (1979). Code modifications developed by Birth Defects & Genetic Diseases Branch, National Center for Environmental Health, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia, USA.
5. Information can be found on the website at: http://www.meddramsso.com/ [Last accessed 4 March 2002].
6. Antiretroviral Pregnancy Registry Steering Committee. Birth Defect Monitoring, Analysis, and Registry Termination Plan for the Antiretroviral Pregnancy Registry. APR Coordinating Center: Wilmington, NC, 2002.